The drugmaker has engaged in $100 billion of M&A in the last year, but CEO Brent Saunders told CNBC it is committed to innovation.» Read More
Pilgrim's Pride is offering to acquire meat producer Hillshire Brands in a deal worth about $5.52 billion.
Emilia Falcetti, Analyst, Japan Healthcare Equity Research at Cantor Fitzgerald, discusses whether Asian pharmaceuticals will follow their global peers in "ditching the diversification model."
The "Squawk on the Street" crew weigh in on the potential merger between tobacco companies Reynolds American and Lorillard.
Activist investor William Ackman told Allergan's board that the CEO has a 'disabling' conflict of interest because a takeover means losing his job.
CNBC's Meg Tirrell reports both Pfizer and AstraZeneca CEOs are facing tough questions by the UK Parliament on the possible merger.
Valeant said it planned to "improve" its $47 billion takeover offer for drugmaker Allergan, a day after the U.S. company rejected the bid.
U.S. medical firm Allergan rejected the unsolicited takeover offer from Valeant Pharmaceuticals, saying it substantially undervalued the company.
Packaged food company Hillshire Brands said it would acquire Pinnacle Foods for about $6.6 billion, including debt, in a cash and stock deal.
Apple knows music and Beats knows putting music in peoples' ears - but beyond that, Wall Street can't see much point in putting the two together.
The $35 billion merger between Omnicom and Publicis has collapsed as challenges proved too immense for the partners.
Comcast's plan to merge with Time Warner Cable is expected to face criticism when U.S. lawmakers meet for a second time to discuss the deal.
Comcast is merging with Time Warner Cable and within a year the X1 cable service should be available to customers in L.A. as well as in New York.
Baoshan Iron and Steel (Baosteel) and Aurizon Holdings launched a A$1.14 billion ($1.06 billion) takeover bid for Aquila Resources.
Employees at Pfizer Inc's U.S. research centers may want to dust off their resumes if the company's proposed acquisition of Britain's AstraZeneca comes to fruition.
As rivals assessed what Pfizer's play for AstraZeneca could mean for the industry, one aspect touched nearly everyone: What it could mean for a U.S. tax loophole.
Wells Fargo's Bonnie Herzog thinks a Lorillard-Reynolds merger would make a profitable combination, reports CNBC's David Faber.
Goodman Fielder said it has received a A$1.3 billion ($1.2 billion) bid from Wilmar International but that the offer undervalues the company.
General Electric is in talks with Alstom to take over its global power business. A deal could be announced in days, two sources said.
Medical device maker Zimmer Holdings said it would buy orthopedic products company Biomet to broaden its portfolio of products that treat bone and joint-related disorders.
Drugmakers eager to satisfy shareholders are wheeling, dealing, and in one case even making trades like a pro sports team looking to shake up its roster.